🚨 SWING TRADE ALERT: $UPB (Upstream Bio) 🚨 - The Catalyst: ( Sep 8, 2026, 3:30 AM) Upstream Bio just delivered a late-breaking oral presentation at the ERS Congress 2026 in Barcelona. The full results from their Phase 2 VALIANT clinical trial for Verekitug in severe asthma are highly impressive:56% reduction in annualized asthma exacerbations (AAER) with a 100mg dose. - Institutions own a massive 92.5% of the company. the effective retail float is only around 4M–5M shares. - Sitting on a massive $261.3 million in cash. - 20% short interest - Triple daily bottom at 5.8 - 09/02/2026 07:35 Upstream Bio Price Target Maintained With a $36.00/Share by HC Wainwright & Co.
active
$UPB short alert
$UPB
Latest documented BWB result
$SPY market result
Exit the rest of the $SPY Strangle for a nice profit
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.